Form 4: Nu Skin Executive Boosts Stake with RSU Vesting
Insider Transaction Report
Nu Skin Enterprises' EVP, President of Global Sales, Justin Keisel, increased his direct beneficial ownership by 37,410 shares through the vesting of restricted stock units.
Summary
- Justin Keisel, EVP, President of Global Sales at Nu Skin Enterprises, Inc. (NUS), acquired 37,410 shares of Class A Common Stock.
- This acquisition occurred on February 10, 2026, through the vesting of restricted stock units (RSUs).
- The vesting was contingent upon Nu Skin Enterprises, Inc. satisfying certain performance criteria.
- Specifically, 2,910 shares vested from an RSU grant made on February 27, 2024.
- An additional 34,500 shares vested from an RSU grant made on February 26, 2025.
- Following these transactions, Keisel's direct beneficial ownership increased to 128,332 shares of Class A Common Stock.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a moderately positive signal, as the vesting of performance-based RSUs indicates the company met its internal targets, and increased insider ownership generally reflects management confidence.
Positives
- The vesting of performance-based restricted stock units indicates that Nu Skin Enterprises, Inc. successfully met specific internal performance criteria.
- Increased insider ownership by a key executive like Justin Keisel aligns management's interests with shareholders, potentially signaling confidence in the company's future prospects.
- The shares were acquired at a price of $0.00, signifying they were awarded as compensation for achieving targets, rather than purchased.
Future Outlook
The vesting of performance-based restricted stock units on a future date (February 10, 2026) implies that the company's management anticipated meeting, and has now met, specific performance targets by that date, suggesting a positive outlook on future operational success.
Management Comments
- On February 27, 2024, the reporting person was granted restricted stock units, the vesting of which was contingent on Nu Skin Enterprises, Inc.'s satisfaction of certain performance criteria. On February 10, 2026, the performance criteria were met, resulting in the amount shown above becoming eligible for vesting.
- On February 26, 2025, the reporting person was granted restricted stock units, the vesting of which was contingent on Nu Skin Enterprises, Inc.'s satisfaction of certain performance criteria. On February 10, 2026, the performance criteria were met, resulting in the amount shown above becoming eligible for vesting.
Industry Context
StockSavvy.ai notes that performance-based RSU vesting is a common practice in executive compensation across various industries, designed to align executive incentives with company performance and shareholder value creation. For direct selling companies like Nu Skin, meeting performance targets can be indicative of successful market penetration, product innovation, or effective sales force management, which are critical drivers in this sector.
Comparison to Industry Standards
- The use of performance-based restricted stock units (RSUs) for executive compensation is a standard practice among publicly traded companies, including direct selling peers like Herbalife Nutrition Ltd. (HLF) and USANA Health Sciences, Inc. (USNA).
- The specific performance criteria for vesting are not disclosed, making a direct comparison of the rigor of these targets to industry benchmarks difficult. However, the successful vesting implies the company achieved its internal goals.
- The increase in direct beneficial ownership for a key executive like Justin Keisel (EVP, President of Global Sales) is generally viewed positively, similar to how increased insider holdings are perceived at companies such as Procter & Gamble (PG) or Estée Lauder (EL), as it suggests management confidence.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Administrative Delegation | A Limited Power of Attorney was granted by Justin Keisel to several individuals, including Ryan Napierski, James Thomas, Chayce Clark, Gregory Belliston, Glen Ellsworth, and Melody Hiatt, to prepare and file SEC Forms 3, 4, 5, and 144 on his behalf. This is a standard administrative procedure to ensure compliance with reporting requirements. | 2025-05-27 | This delegation streamlines the process for insider reporting and ensures timely compliance with SEC regulations, without altering the company's core governance structure or executive roles. |
Related Party Transactions
- The vesting of 37,410 shares of Class A Common Stock to Justin Keisel, an executive officer, constitutes a related party transaction as it represents compensation from the company to an insider.
Stakeholder Impact
- Shareholders: The successful vesting of performance-based RSUs suggests the company met its internal goals, which could be positive for shareholder confidence. Increased insider ownership aligns executive interests with shareholders.
- Employees: The successful vesting of performance-based awards can reinforce a culture of achievement and reward for meeting company objectives.
Next Steps
- Justin Keisel will continue to hold the newly vested shares, subject to any future sales or grants.
- The company will continue to monitor and report insider transactions as required by Section 16(a) of the Securities Exchange Act of 1934.
Key Dates
| Date | Description |
|---|---|
| 2024-02-27 | Date of restricted stock unit grant for 2,910 shares. |
| 2025-02-26 | Date of restricted stock unit grant for 34,500 shares. |
| 2025-05-27 | Date the Limited Power of Attorney was executed by Justin Keisel. |
| 2026-02-10 | Date performance criteria were met, resulting in the vesting of both restricted stock unit grants. |
| 2026-02-12 | Date the Form 4 was signed by Gregory Belliston as Attorney-in-Fact. |
Recommendation
holdThis Form 4 filing reports a routine, albeit significant in volume, vesting of performance-based restricted stock units for a key executive. While the successful vesting indicates the company met its internal performance criteria, and increased insider ownership is generally positive, this event alone does not provide new fundamental information to warrant a change in investment thesis. It confirms past performance targets were met, which is expected for a well-managed company. Therefore, a 'hold' recommendation is appropriate, maintaining existing positions based on broader company fundamentals rather than this specific insider transaction.
Keywords
Nu Skin Enterprises, NUS, Justin Keisel, Form 4, Insider Transaction, Restricted Stock Units, RSU Vesting, Executive Compensation, Stock Grant, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.